Wockhardt Ltd
Gaurav Mehta has extensive experience in the pharmaceutical industry, currently serving as Deputy General Manager at Wockhardt Research Centre since 2006, where responsibilities include strategic planning, dossier outlicensing, product outsourcing, business development, project management, and technology transfer for various markets including the USA and EU. Previous roles at Wockhardt include Senior Manager and Group Leader, focusing on process development. Prior to joining Wockhardt, Gaurav Mehta worked as a Research Scientist at Ranbaxy Research Lab from 2001 to 2006. Gaurav Mehta holds an education credential from Panjab University, completed between 1999 and 2001.
This person is not in any teams
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.